Global Patent Index - EP 0778835 A4

EP 0778835 A4 19990203 - 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS

Title (en)

7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS

Title (de)

7-AZABICYCLO (2.2.1)-HEPTAN- UND -HEPTEN- DERIVATE ALS LIGANDEN DER CHOLIENERGISCHEN REZEPTOREN

Title (fr)

DERIVES DE 7-AZABICYCLO 2.2.1]-HEPTANE ET -HEPTENE UTILISES COMME LIGANDS DES RECEPTEURS CHOLINERGIQUES

Publication

EP 0778835 A4 19990203 (EN)

Application

EP 95932333 A 19950825

Priority

  • US 29646394 A 19940825
  • US 255195 P 19950821
  • US 9510884 W 19950825

Abstract (en)

[origin: CA2196979A1] 7-Azabicyclo¢2.2.1!-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.

IPC 1-7

C07D 401/04; C07D 403/04; C07D 407/04; C07D 409/04; C07D 413/04; C07D 417/04; C07D 419/04; A61K 31/40; A61K 31/415; A61K 31/42; A61K 31/425

IPC 8 full level

C07D 487/08 (2006.01); A61K 31/395 (2006.01); A61K 31/40 (2006.01); A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/425 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/50 (2006.01); A61K 31/505 (2006.01); A61K 31/53 (2006.01); A61K 31/535 (2006.01); A61K 31/54 (2006.01); A61K 31/675 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 407/04 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 419/04 (2006.01); C07D 519/00 (2006.01); C07F 9/6561 (2006.01)

Citation (search report)

  • [X] EP 0382687 A2 19900816 - ANGELI INST SPA [IT]
  • [PX] WO 9422868 A1 19941013 - UNIV VIRGINIA [US], et al
  • [PX] EP 0657455 A1 19950614 - EGYT GYOGYSZERVEGYESZETI GYAR [HU]
  • [A] DE 3445377 A1 19850704 - SANDOZ AG [DE]
  • [X] S. F. NELSEN ET AL: "The nitrogen inversion barrier of 7-methyl-7-azabicyclo(2.2.1)heptane and the "bicyclic effect"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 111, 1989, DC US, pages 1776 - 1781, XP002086467
  • [X] A. P. KRAPCHO ET AL: "The synthesis of a cocaine intermediate via a sodium-liquid ammonia carbon-carbon sigma-bond cleavage of an azabicyclic succinate-type ester", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS, 1985, LETCHWORTH GB, pages 233 - 234, XP002086468
  • [DX] S. R. FLETCHER ET AL: "Total synthesis and determination of the absolute configuration of epibatidine", JOURNAL OF ORGANIC CHEMISTRY, vol. 59, no. 7, 1994, EASTON US, pages 1771 - 1778, XP002086469
  • [PX] DATABASE WPI Week 9518, Derwent World Patents Index; AN 95-136801, XP002086471, "Novel aza-bicycloheptane deriv(s). - useful for treating Alzheimer's disease, Parkinson's disease, hypertension, tobacco dependence etc."
  • [PX] A. HASSNER ET AL: "A simple method of preparation of 7-alkyl-7-azabicyclo(2.2.1)heptanes", TETRAHEDRON LETTERS, vol. 36, no. 10, 1995, OXFORD GB, pages 1709 - 1712, XP002086470
  • See references of WO 9606093A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

AU 3540695 A 19960314; AU 708112 B2 19990729; CA 2196979 A1 19960229; CN 1071753 C 20010926; CN 1163613 A 19971029; EP 0778835 A1 19970618; EP 0778835 A4 19990203; JP 2002504883 A 20020212

DOCDB simple family (application)

AU 3540695 A 19950825; CA 2196979 A 19950825; CN 95195674 A 19950825; EP 95932333 A 19950825; JP 50831096 A 19950825